JVJoseph P. Vacanti

Joseph P. Vacanti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Joseph P. Vacanti has a total of 87 co-authors. Here are the top co-authors by number of shared publications:

  • Irina Pomerantseva

    Department of Surgery, Massachusetts General Hospital, Boston, MA, USA ; Center for Regenerative Medicine, Boston, MA, USA ; Harvard Medical School, Boston, MA, USA

    5 shared publications
  • David M. Hoganson

    Department of Cardiac Surgery, Boston Children's Hospital, Boston, Mass

    4 shared publications
  • Erik K. Bassett

    Department of Surgery, Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts

    4 shared publications
  • Alan Tseng

    Department of Surgery, Massachusetts General Hospital , Boston, Massachusetts

    3 shared publications
  • Cathryn A. Sundback

    Department of Surgery, Massachusetts General Hospital, Boston, MA, USA ; Center for Regenerative Medicine, Boston, MA, USA ; Harvard Medical School, Boston, MA, USA

    3 shared publications
  • Michael Shin

    Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA

    3 shared publications

Latest Publications

  • Tissue engineering: from the bedside to the bench and back to the bedside

    by Tatevik Sahakyants, Joseph P. Vacanti

    The field of Tissue Engineering and Regenerative Medicine has evolved rapidly over the past thirty years. This review will summarize its history, current status and direction through the lens of clinical need, its progress through science in the laboratory and application back into patients. We can take pride in the fact that much effort and progress began with the surgical problems of children and that many surgeons in the pediatric surgical specialties have become pioneers and investigators in this new field of science, engineering, and medicine. Although the field has yet to fulfill its great promise, there have been several examples where a therapy has progressed from the first idea to human application within a short span of time and, in many cases, it has been applied in the surgical care of children.


  • Decellularized extracellular matrix microparticles as a vehicle for cellular delivery in a model of anastomosis healing

    by David M. Hoganson, Gwen E. Owens, Amanda M. Meppelink, Erik K. Bassett, Chris M. Bowley, Cameron J. Hinkel, Eric B. Finkelstein, Scott M. Goldman, Joseph P. Vacanti

    Extracellular matrix (ECM) materials from animal and human sources have become important materials for soft tissue repair. Microparticles of ECM materials have increased surface area and exposed binding sites compared to sheet materials. Decellularized porcine peritoneum was mechanically dissociated into 200 µm microparticles, seeded with fibroblasts and cultured in a low gravity rotating bioreactor. The cells avidly attached and maintained excellent viability on the microparticles. When the seeded microparticles were placed in a collagen gel, the cells quickly migrated off the microparticles and through the gel. Cells from seeded microparticles migrated to and across an in vitro anastomosis model, increasing the tensile strength of the model. Cell seeded microparticles of ECM material have potential for paracrine and cellular delivery therapies when delivered in a gel carrier. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1728-1735, 2016.


  • Ear-Shaped Stable Auricular Cartilage Engineered from Extensively Expanded Chondrocytes in an Immunocompetent Experimental Animal Model

    by Irina Pomerantseva, David A. Bichara, Alan Tseng, Michael J. Cronce, Thomas M. Cervantes, Anya M. Kimura, Craig M. Neville, Nick Roscioli, Joseph P. Vacanti, Mark A. Randolph, et al.

    Advancement of engineered ear into clinical practice is limited by several challenges. The complex, largely unsupported three-dimensional auricular neocartilage structure is difficult to maintain. Neocartilage formation is challenging in an immunocompetent host due to active inflammatory and immunological responses. The large number of autologous chondrogenic cells required for engineering an adult human-sized ear presents an additional challenge because primary chondrocytes rapidly dedifferentiate during in vitro culture. The objective of this study was to engineer stable human ear-shaped cartilage in an immunocompetent animal model using expanded chondrocytes. The impact of basic fibroblast growth factor (bFGF) supplementation on achieving clinically relevant expansion of primary sheep chondrocytes by in vitro culture was determined. Chondrocytes expanded in standard medium were either combined with cryopreserved primary passage 0 chondrocytes at the time of scaffold seeding or used alone, as control. Disk and human ear-shaped scaffolds were made from porous collagen; ear scaffolds had an embedded supporting titanium wire framework. Autologous chondrocyte-seeded scaffolds were implanted subcutaneously in sheep after 2 weeks of in vitro incubation. The quality of the resulting neocartilage, its stability and retention of the original ear size and shape were evaluated at 6, 12, and 20 weeks post implantation. Neocartilage produced from chondrocytes expanded in the presence of bFGF was superior and its quality improved with increased implantation time. In addition to characteristic morphological cartilage features, its glycosaminoglycan content was high and marked elastin fiber formation was present. The overall shape of engineered ears was preserved at 20 weeks post implantation and the dimensional changes did not exceed 10%. The wire frame within the engineered ear was able to withstand mechanical forces during wound healing and neocartilage maturation and prevented shrinkage and distortion. This is the first demonstration of stable ear-shaped elastic cartilage engineered from auricular chondrocytes that underwent clinical-scale expansion, in an immunocompetent animal over an extended period of time.


  • Top Cited Papers
    Open Access

    Advances in tissue engineering

    by Robert Langer, Joseph Vacanti


  • Gas Transfer in Cellularized Collagen-Membrane Gas Exchange Devices

    by Justin H. Lo, Erik K. Bassett, Elliot J. N. Penson, David M. Hoganson, Joseph P. Vacanti

    Chronic lower respiratory disease is highly prevalent in the United States, and there remains a need for alternatives to lung transplant for patients who progress to end-stage lung disease. Portable or implantable gas oxygenators based on microfluidic technologies can address this need, provided they operate both efficiently and biocompatibly. Incorporating biomimetic materials into such devices can help replicate native gas exchange function and additionally support cellular components. In this work, we have developed microfluidic devices that enable blood gas exchange across ultra-thin collagen membranes (as thin as 2 μm). Endothelial, stromal, and parenchymal cells readily adhere to these membranes, and long-term culture with cellular components results in remodeling, reflected by reduced membrane thickness. Functionally, acellular collagen-membrane lung devices can mediate effective gas exchange up to ∼288 mL/min/m(2) of oxygen and ∼685 mL/min/m(2) of carbon dioxide, approaching the gas exchange efficiency noted in the native lung. Testing several configurations of lung devices to explore various physical parameters of the device design, we concluded that thinner membranes and longer gas exchange distances result in improved hemoglobin saturation and increases in pO2. However, in the design space tested, these effects are relatively small compared to the improvement in overall oxygen and carbon dioxide transfer by increasing the blood flow rate. Finally, devices cultured with endothelial and parenchymal cells achieved similar gas exchange rates compared with acellular devices. Biomimetic blood oxygenator design opens the possibility of creating portable or implantable microfluidic devices that achieve efficient gas transfer while also maintaining physiologic conditions.


  • Open Access

    Extensively Expanded Auricular Chondrocytes Form Neocartilage In Vivo

    by Alan Tseng, Irina Pomerantseva, Michael J. Cronce, Anya M. Kimura, Craig M. Neville, Mark A. Randolph, Joseph P. Vacanti, Cathryn A. Sundback

    Objective: Our goal was to engineer cartilage in vivo using auricular chondrocytes that underwent clinically relevant expansion and using methodologies that could be easily translated into health care practice. Design: Sheep and human chondrocytes were isolated from auricular cartilage biopsies and expanded in vitro . To reverse dedifferentiation, expanded cells were either mixed with cryopreserved P0 chondrocytes at the time of seeding onto porous collagen scaffolds or proliferated with basic fibroblast growth factor (bFGF). After 2-week in vitro incubation, seeded scaffolds were implanted subcutaneously in nude mice for 6 weeks. The neocartilage quality was evaluated histologically; DNA and glycosaminoglycans were quantified. Cell proliferation rates and collagen gene expression profiles were assessed. Results: Clinically sufficient over 500-fold chondrocyte expansion was achieved at passage 3 (P3); cell dedifferentiation was confirmed by the simultaneous COL1A1/3A1 gene upregulation and COL2A1 downregulation. The chondrogenic phenotype of sheep but not human P3 cells was rescued by addition of cryopreserved P0 chondrocytes. With bFGF supplementation, chondrocytes achieved clinically sufficient expansion at P2; COL2A1 expression was not rescued but COL1A1/3A1genes were downregulated. Although bFGF failed to rescue COL2A1 expression during chondrocyte expansion in vitro , elastic neocartilage with obvious collagen II expression was observed on porous collagen scaffolds after implantation in mice for 6 weeks. Conclusions: Both animal and human auricular chondrocytes expanded with low-concentration bFGF supplementation formed high-quality elastic neocartilage on porous collagen scaffolds in vivo .


  • Open Access

    Design of composite scaffolds and three-dimensional shape analysis for tissue-engineered ear

    by Thomas M. Cervantes, Erik K. Bassett, Alan Tseng, Anya Kimura, Nick Roscioli, Mark A. Randolph, Joseph P. Vacanti, Theresa A. Hadlock, Rajiv Gupta, Irina Pomerantseva, et al.

    Engineered cartilage is a promising option for auricular reconstruction. We have previously demonstrated that a titanium wire framework within a composite collagen ear-shaped scaffold helped to maintain the gross dimensions of the engineered ear after implantation, resisting the deformation forces encountered during neocartilage maturation and wound healing. The ear geometry was redesigned to achieve a more accurate aesthetic result when implanted subcutaneously in a nude rat model. A non-invasive method was developed to assess size and shape changes of the engineered ear in three dimensions. Computer models of the titanium framework were obtained from CT scans before and after implantation . Several parameters were measured including the overall length, width and depth, the minimum intrahelical distance and overall curvature values for each beam section within the framework. Local curvature values were measured to gain understanding of the bending forces experienced by the framework structure in situ . Length and width changed by less than 2%, whereas the depth decreased by approximately 8% and the minimum intrahelical distance changed by approximately 12%. Overall curvature changes identified regions most susceptible to deformation. Eighty-nine per cent of local curvature measurements experienced a bending moment less than 50 µN-m owing to deformation forces during implantation. These quantitative shape analysis results have identified opportunities to improve shape fidelity of engineered ear constructs.


  • Tissue engineering and the road to whole organs

    by J. P. Vacanti

    A glimpse into the future of surgery